The only two companies to have double-digit sales increases by revenue in 2023 were Novo Nordisk’s Ozempic and Eli Lily’s Mounjaro, mostly due to the popularity of injected weight loss drugs. Their revenue increase was 31% and 20% respectively.
Click here to view the entire list.